The Validity of Claims-Based Algorithms to Identify Serious Hypersensitivity Reactions and Osteonecrosis of the Jaw

PLoS One. 2015 Jul 10;10(7):e0131601. doi: 10.1371/journal.pone.0131601. eCollection 2015.

Abstract

Validation of claims-based algorithms to identify serious hypersensitivity reactions and osteonecrosis of the jaw has not been performed in large osteoporosis populations. The objective of this project is to estimate the positive predictive value of the claims-based algorithms in older women with osteoporosis enrolled in Medicare. Using the 2006-2008 Medicare 5% sample data, we identified potential hypersensitivity and osteonecrosis of the jaw cases based on ICD-9 diagnosis codes. Potential hypersensitivity cases had a 995.0, 995.2, or 995.3 diagnosis code on emergency department or inpatient claims. Potential osteonecrosis of the jaw cases had ≥1 inpatient or outpatient physician claim with a 522.7, 526.4, 526.5, or 733.45 diagnosis code or ≥2 claims of any type with a 526.9 diagnosis code. All retrieved records were redacted and reviewed by experts to determine case status: confirmed, not confirmed, or insufficient information. We calculated the positive predictive value as the number of confirmed cases divided by the total number of retrieved records with sufficient information. We requested 412 potential hypersensitivity and 304 potential osteonecrosis of the jaw records and received 174 (42%) and 84 (28%) records respectively. Of 84 potential osteonecrosis of the jaw cases, 6 were confirmed, resulting in a positive predictive value (95% CI) of 7.1% (2.7, 14.9). Of 174 retrieved potential hypersensitivity records, 95 were confirmed. After exclusion of 25 records with insufficient information for case determination, the overall positive predictive value (95% CI) for hypersensitivity reactions was 76.0% (67.5, 83.2). In a random sample of Medicare data, a claim-based algorithm to identify serious hypersensitivity reactions performed well. An algorithm for osteonecrosis of the jaw did not, partly due to the inclusion of diagnosis codes that are not specific for osteoporosis of the jaw.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Algorithms*
  • Female
  • Humans
  • Hypersensitivity / complications
  • Hypersensitivity / diagnosis*
  • Insurance Claim Review / statistics & numerical data*
  • International Classification of Diseases
  • Jaw Diseases / complications
  • Jaw Diseases / diagnosis*
  • Medicare / statistics & numerical data
  • Osteonecrosis / complications
  • Osteonecrosis / diagnosis*
  • Osteoporosis, Postmenopausal / complications
  • Reproducibility of Results
  • Retrospective Studies
  • Sensitivity and Specificity
  • United States

Grants and funding

This project was funded by a contract between UAB and Amgen, Inc. All authors received research support from Amgen, Inc. Amgen played a role in the study design by providing the algorithms evaluated in our project. However, they played no role in data collection and analysis. Per contract policies for the parent project of this study, all manuscripts are reviewed by Amgen prior to submission for a 30 day, non-binding courtesy review. Publication of the manuscript was not conditional on approval from Amgen.